PORTFOLIO NEWS Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials June 19, 2020 Read More » Rapt Therapeutics Appoints Peter Svennilson to Board of Directors June 18, 2020 Read More » Revolution Medicines Appoints Peter Svennilson to its Board of Directors June 18, 2020 Read More » Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team June 16, 2020 Read More » Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock June 16, 2020 Read More » Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise June 12, 2020 Read More » Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 June 9, 2020 Read More » Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration June 4, 2020 Read More » Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock May 28, 2020 Read More » Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board May 27, 2020 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials June 19, 2020 Read More »
Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team June 16, 2020 Read More »
Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock June 16, 2020 Read More »
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise June 12, 2020 Read More »
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 June 9, 2020 Read More »
Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration June 4, 2020 Read More »
Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock May 28, 2020 Read More »
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board May 27, 2020 Read More »
